出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2022年8月
レジオネラ検査市場：検査の種類 (培養、尿中抗原検査、DFA、PCR)、用途 ［水および IVD 検査 (尿、血液)］、エンドユーザー (病院、診療所、診断ラボ、水処理産業)、地域別 – 2027 年までの世界予測
Legionella Testing Market by Test Type (Culture, Urinary Antigen Test, DFA, PCR), Application (Water & IVD Testing (Urine, Blood)), End User (Hospitals, Clinics, Diagnostic Labs, Water Treatment Industries), Region – Global Forecast to 2027
| ページ数 | 203 |
| 図表数 | 193 |
| 種別 | 英文調査報告書 |
| 価格 |
MarketsandMarkets（マーケッツアンドマーケッツ）「レジオネラ検査市場：検査の種類 (培養、尿中抗原検査、DFA、PCR)、用途 ［水および IVD 検査 (尿、血液)］、エンドユーザー (病院、診療所、診断ラボ、水処理産業)、地域別 – 2027 年までの世界予測 – Legionella Testing Market by Test Type (Culture, Urinary Antigen Test, DFA, PCR), Application (Water & IVD Testing (Urine, Blood)), End User (Hospitals, Clinics, Diagnostic Labs, Water Treatment Industries), Region – Global Forecast to 2027」は世界のレジオネラ菌検査市場を調査し、主要セグメント毎に行った分析・予測結果を提供します。
The global legionella testing market is projected to reach USD 439 million by 2027 from USD 296 million in 2022, at a CAGR of 8.2% during the forecast period. Growth in this market is mainly driven by the rising geriatric population coupled with increasing prevalence of legionella-related illness, and rising demand for rapid diagnostics.
“The PCR segment accounted for the highest growth rate in the legionella testing market, by test type, during the forecast period.”
The legionella testing market is segmented into culture methods, urinary antigen tests, direct fluorescent antibody tests, and PCR based on product. In 2021, the PCR segment accounted for the highest growth rate in the legionella testing market. Market growth can largely be attributed to its speed, versatility, and simplicity.
“Water & Other Industries segment accounted for the highest CAGR.”
Based on the end user, the legionella testing market has been segmented into hospitals, diagnostic laboratories, water & other industries, and other end user. In 2021, the water & other industries segment accounted for the highest growth rate. This can be attributed to the rising population and urbanization, and the increased demand for new water resources
“Asia Pacific: The fastest-growing region legionella testing market.”
The global legionella testing market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Factors such as government efforts to increase awareness about the early disease diagnosis and regular health check-ups
The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 -30%
• By Designation: C-level – 27%, D-level – 18%, and Others – 55%
• By Region: North America -51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and the Middle East & Africa – 4%
Lists of Companies Profiled in the Report:
• Thermo Fisher Scientific, Inc. (US)
• Merck KGaA (Germany)
• Bio-Rad Laboratories, Inc. (US)
• IDEXX Laboratories, Inc. (US)
• bioMérieux S.A. (France)
• Becton, Dickinson, and Company (US)
• Alere, Inc. (US)
• Eurofins Scientific (Luxembourg)
• Roche Diagnostics (Switzerland)
• Pall Corporation (Danaher) (US)
• Quidel Corporation (US)
• Eiken Chemical Co., Ltd. (Japan)
• Hologic, Inc. (US)
• QIAGEN (Germany)
• Takara Bio, Inc. (Japan)
• Environmental Safety Technologies, Inc. (US)
• Hydrosense (Scotland)
• Accepta Ltd. (UK)
• LuminUltra Technologies Ltd. (Canada)
• Pro-Lab Diagnostics, Inc. (Canada)
• BioAlert Solutions (Canada)
• Pacific Water Technology (Australia)
• Aquacert Ltd. (UK)
• DTK Water (UK)
• Sens Solutions (Spain)
• Genomadix, Inc. (US)
• Phigenics, LLC (US).
Research Coverage:
This report provides a detailed picture of the global legionella testingmarket. It aims at estimating the size and future growth potential of the market across different segments, such as test type, application, end user, and region. The report also includes an in-depth competitive analysis of the key market player, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall legionella testing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
目次
TABLE OF CONTENTS
1 INTRODUCTION (Page No. – 27)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
TABLE 1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 LIMITATIONS
1.7 STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. – 30)
2.1 RESEARCH DATA
FIGURE 1 LEGIONELLA TESTING MARKET: RESEARCH DESIGN METHODOLOGY
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
TABLE 2 KEY DATA FROM PRIMARY SOURCES
FIGURE 2 KEY INDUSTRY INSIGHTS
2.1.2.2 Breakdown of primary interviews
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (LEGIONELLA TESTING MARKET)
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.2.1.2 Approach 2: Presentations of companies and primary interviews
2.2.1.3 Growth forecast
2.2.1.4 CAGR projections
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.2.2 TOP-DOWN APPROACH
FIGURE 7 LEGIONELLA TESTING MARKET: TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.5 LIMITATIONS AND RISK ASSESSMENT
FIGURE 9 LIMITATIONS: LEGIONELLA TESTING MARKET
TABLE 3 RISK ASSESSMENT: LEGIONELLA TESTING MARKET
3 EXECUTIVE SUMMARY (Page No. – 42)
FIGURE 10 LEGIONELLA TESTING MARKET, BY TEST TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 11 LEGIONELLA TESTING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 12 LEGIONELLA TESTING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 13 LEGIONELLA TESTING MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)
4 PREMIUM INSIGHTS (Page No. – 45)
4.1 LEGIONELLA TESTING MARKET OVERVIEW
FIGURE 14 GROWING PREVALENCE OF LEGIONELLA-RELATED ILLNESS AND RISING GERIATRIC POPULATION TO DRIVE MARKET GROWTH
4.2 LEGIONELLA TESTING MARKET SHARE, BY TEST TYPE, 2022 VS. 2027
FIGURE 15 PCR SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2027
4.3 LEGIONELLA TESTING MARKET SHARE, BY APPLICATION, 2022 VS. 2027
FIGURE 16 WATER TESTING SEGMENT TO HOLD LARGEST MARKET SHARE
4.4 LEGIONELLA TESTING MARKET SHARE, BY END USER, 2022 VS. 2027
FIGURE 17 WATER & OTHER INDUSTRIES TO CONTINUE TO DOMINATE MARKET IN 2027
4.5 LEGIONELLA TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE
5 MARKET OVERVIEW (Page No. – 48)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 LEGIONELLA TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising incidence of pneumonia and legionella-related illnesses
5.2.1.2 Increasing demand for rapid advanced diagnostic technologies
5.2.1.3 Technological advancements in bacterial testing
5.2.1.4 Stringent regulations for regular water testing
5.2.2 RESTRAINTS
5.2.2.1 Lack of reimbursement policies
5.2.3 OPPORTUNITIES
5.2.3.1 Opportunities in growing economies
5.2.3.2 Legal requirements for water testing
5.2.4 CHALLENGES
5.2.4.1 Difficulties in detection
5.2.4.2 Limited awareness in underdeveloped countries
5.2.4.3 High health costs associated with Legionella
5.3 PRICING ANALYSIS
TABLE 4 AVERAGE SELLING PRICE OF LEGIONELLA TESTING PRODUCTS (2022)
5.4 PATENT ANALYSIS
FIGURE 20 PATENT ANALYSIS FOR MOTORIZED LEGIONELLA TESTING DEVICES
TABLE 5 LIST OF KEY PATENTS
5.5 VALUE CHAIN ANALYSIS
FIGURE 21 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 22 LEGIONELLA TESTING MARKET: SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM/MARKET MAP
FIGURE 23 LEGIONELLA TESTING MARKET: ECOSYSTEM/MARKET MAP
TABLE 6 LEGIONELLA TESTING MARKET: ROLE IN ECOSYSTEM
5.8 PORTER’S FIVE FORCES ANALYSIS
TABLE 7 LEGIONELLA TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF BUYERS
5.8.4 BARGAINING POWER OF SUPPLIERS
5.8.5 DEGREE OF COMPETITION
5.9 PESTEL ANALYSIS
5.9.1 POLITICAL FACTORS
5.9.2 ECONOMIC FACTORS
5.9.3 SOCIAL FACTORS
5.9.4 TECHNOLOGICAL FACTORS
5.9.5 ENVIRONMENTAL FACTORS
5.9.6 LEGAL FACTORS
5.10 REGULATORY LANDSCAPE
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10.1 NORTH AMERICA
5.10.1.1 US
5.10.1.2 Canada
5.10.2 EUROPE
5.10.3 ASIA PACIFIC
5.10.3.1 Japan
5.10.3.2 India
5.10.4 LATIN AMERICA
5.10.4.1 Brazil
5.10.4.2 Mexico
5.10.5 MIDDLE EAST
5.10.6 AFRICA
5.11 TRADE ANALYSIS
5.11.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
TABLE 13 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2017–2021 (USD MILLION)
TABLE 14 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2017–2021 (USD MILLION)
5.12 TECHNOLOGY ANALYSIS
5.13 KEY CONFERENCES & EVENTS IN 2022–2023
TABLE 15 LEGIONELLA TESTING MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 24 REVENUE SHIFT IN THE LEGIONELLA TESTING MARKET
5.15 KEY STAKEHOLDERS & BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 25 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF LEGIONELLA TESTING PRODUCTS
TABLE 16 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF LEGIONELLA TESTING PRODUCTS
5.15.2 BUYING CRITERIA
FIGURE 26 KEY BUYING CRITERIA FOR LEGIONELLA TESTING PRODUCTS
TABLE 17 KEY BUYING CRITERIA FOR LEGIONELLA TESTING PRODUCTS
5.16 CASE STUDIES
6 LEGIONELLA TESTING MARKET, BY TEST TYPE (Page No. – 75)
6.1 INTRODUCTION
TABLE 18 LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
6.2 PCR
6.2.1 INCREASED USAGE OF PCR TO SUPPORT MARKET GROWTH
TABLE 19 KEY PCR PRODUCTS AVAILABLE IN THE MARKET
TABLE 20 LEGIONELLA TESTING MARKET FOR PCR, BY REGION, 2020–2027 (USD MILLION)
6.3 CULTURE METHODS
6.3.1 HIGHER SPECIFICITY AND SENSITIVITY TO DRIVE MARKET
TABLE 21 KEY CULTURE METHODS AVAILABLE IN THE MARKET
TABLE 22 LEGIONELLA TESTING MARKET FOR CULTURE METHODS, BY REGION, 2020–2027 (USD MILLION)
6.4 URINARY ANTIGEN TESTS
6.4.1 RAPID OUTCOMES TO DRIVE MARKET GROWTH
TABLE 23 KEY URINARY ANTIGEN TESTS AVAILABLE IN THE MARKET
TABLE 24 LEGIONELLA TESTING MARKET FOR URINARY ANTIGEN TESTS, BY REGION, 2020–2027 (USD MILLION)
6.5 DIRECT FLUORESCENT ANTIBODY TESTS
6.5.1 RAPIDITY AND EASE OF USE TO BOOST ADOPTION OF TESTS
TABLE 25 LEGIONELLA TESTING MARKET FOR DIRECT FLUORESCENT ANTIBODY TESTS, BY REGION, 2020–2027 (USD MILLION)
7 LEGIONELLA TESTING MARKET, BY APPLICATION (Page No. – 81)
7.1 INTRODUCTION
TABLE 26 LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
7.2 WATER TESTING
TABLE 27 LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 28 LEGIONELLA TESTING MARKET FOR WATER TESTING, BY REGION, 2020–2027 (USD MILLION)
7.2.1 PCR
7.2.1.1 Rapid diagnosis to spur segment growth
TABLE 29 WATER TESTING MARKET FOR PCR, BY REGION, 2020–2027 (USD MILLION)
7.2.2 MICROBIAL CULTURE
7.2.2.1 Long incubation periods make isolation difficult, affecting adoption of culture techniques
TABLE 30 WATER TESTING MARKET FOR MICROBIAL CULTURE, BY REGION, 2020–2027 (USD MILLION)
7.2.3 DFA STAIN
7.2.3.1 High test specificity to drive adoption of DFA staining
TABLE 31 WATER TESTING MARKET FOR DFA STAIN, BY REGION, 2020–2027 (USD MILLION)
7.3 IVD TESTING
TABLE 32 LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 33 LEGIONELLA TESTING MARKET FOR IVD TESTING, BY REGION, 2020–2027 (USD MILLION)
7.3.1 URINE ANTIGEN TESTS
7.3.1.1 Rapid and early diagnosis capabilities to drive market growth
TABLE 34 IVD TESTING MARKET FOR URINE ANTIGEN TESTS, BY REGION, 2020–2027 (USD MILLION)
7.3.2 PCR
7.3.2.1 Emergence of advanced technologies such as qRT-PCR to support market growth
TABLE 35 IVD TESTING MARKET FOR PCR, BY REGION, 2020–2027 (USD MILLION)
7.3.3 BLOOD CULTURE & SPUTUM TESTS
7.3.3.1 Longer incubation period resulting in lower adoption of blood culture techniques
TABLE 36 IVD TESTING MARKET FOR BLOOD CULTURE & SPUTUM TESTS, BY REGION, 2020–2027 (USD MILLION)
7.3.4 DFA STAIN
7.3.4.1 Sensitivity variations affect use of DFA staining in IVD tests
TABLE 37 IVD TESTING MARKET FOR DFA STAIN, BY REGION, 2020–2027 (USD MILLION)
7.4 OTHER APPLICATIONS
TABLE 38 LEGIONELLA TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
8 LEGIONELLA TESTING MARKET, BY END USER (Page No. – 92)
8.1 INTRODUCTION
TABLE 39 LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 WATER & OTHER INDUSTRIES
8.2.1 STRINGENT REGULATIONS AND GROWING POPULATION TO DRIVE MARKET GROWTH
TABLE 40 LEGIONELLA TESTING MARKET FOR WATER & OTHER INDUSTRIES, BY REGION, 2020–2027 (USD MILLION)
8.3 DIAGNOSTIC LABORATORIES
8.3.1 HEALTHCARE INFRASTRUCTURE IMPROVEMENTS TO BOOST MARKET GROWTH
TABLE 41 LEGIONELLA TESTING MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020–2027 (USD MILLION)
8.4 HOSPITALS
8.4.1 INCREASING ADOPTION OF DIAGNOSTIC TOOLS TO SUPPORT MARKET GROWTH
TABLE 42 LEGIONELLA TESTING MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION)
8.5 OTHER END USERS
TABLE 43 LEGIONELLA TESTING MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)
9 LEGIONELLA TESTING MARKET, BY REGION (Page No. – 97)
9.1 INTRODUCTION
TABLE 44 LEGIONELLA TESTING MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: LEGIONELLA TESTING MARKET SNAPSHOT
TABLE 45 NORTH AMERICA: LEGIONELLA TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 46 NORTH AMERICA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 47 NORTH AMERICA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 48 NORTH AMERICA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 Strong presence of major market players to drive growth
TABLE 49 US: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 50 US: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 51 US: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 52 US: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 53 US: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising incidence of lifestyle diseases to drive market growth
TABLE 54 CANADA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 55 CANADA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 56 CANADA: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 CANADA: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 58 CANADA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3 EUROPE
TABLE 59 EUROPE: LEGIONELLA TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 60 EUROPE: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 61 EUROPE: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 62 EUROPE: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany dominates Legionella testing market in Europe
TABLE 63 GERMANY: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 64 GERMANY: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 65 GERMANY: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 66 GERMANY: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 67 GERMANY: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.2 UK
9.3.2.1 Growing number of accredited diagnostic laboratories to propel market growth
TABLE 68 UK: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 69 UK: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 70 UK: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 UK: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 UK: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Rising R&D expenditure and increasing demand for early diagnosis to drive market growth
TABLE 73 FRANCE: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 74 FRANCE: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 75 FRANCE: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 76 FRANCE: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 77 FRANCE: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Adoption of advanced diagnostic technologies to drive market growth
TABLE 78 ITALY: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 79 ITALY: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 80 ITALY: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 ITALY: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 82 ITALY: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising geriatric population to drive market growth
TABLE 83 SPAIN: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 84 SPAIN: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 85 SPAIN: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 SPAIN: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 87 SPAIN: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 88 ROE: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 89 ROE: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 90 ROE: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 91 ROE: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 92 ROE: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 28 APAC: LEGIONELLA TESTING MARKET SNAPSHOT
TABLE 93 ASIA PACIFIC: LEGIONELLA TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 94 ASIA PACIFIC: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 95 ASIA PACIFIC: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 96 ASIA PACIFIC: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.1 CHINA
9.4.1.1 Growing public access to modern healthcare to drive market growth
TABLE 97 CHINA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 98 CHINA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 99 CHINA: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 100 CHINA: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 101 CHINA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Universal healthcare reimbursement policy to drive market growth
TABLE 102 JAPAN: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 103 JAPAN: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 104 JAPAN: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 105 JAPAN: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 106 JAPAN: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Increasing private & public investments in healthcare to drive market growth
TABLE 107 INDIA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 108 INDIA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 109 INDIA: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 110 INDIA: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 111 INDIA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 112 ROAPAC: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 113 ROAPAC: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 114 ROAPAC: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 115 ROAPAC: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 ROAPAC: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 RISING HEALTHCARE EXPENDITURE TO DRAW FOREIGN PLAYERS
TABLE 117 LATIN AMERICA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 118 LATIN AMERICA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 119 LATIN AMERICA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 RISING ACCESS TO ADVANCED TECHNOLOGIES AND GROWING INVESTMENTS TO SUPPORT MARKET GROWTH
TABLE 120 MIDDLE EAST & AFRICA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 121 MIDDLE EAST & AFRICA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 122 MIDDLE EAST & AFRICA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. – 136)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE LEGIONELLA TESTING MARKET
TABLE 123 STRATEGIC DEVELOPMENTS REPORTED
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 29 REVENUE SHARE ANALYSIS OF TOP PLAYERS
10.4 MARKET SHARE ANALYSIS
10.4.1 LEGIONELLA TESTING MARKET
FIGURE 30 LEGIONELLA TESTING MARKET SHARE, BY KEY PLAYER (2021)
TABLE 124 LEGIONELLA TESTING MARKET: DEGREE OF COMPETITION
10.5 COMPANY EVALUATION MATRIX
10.5.1 LIST OF EVALUATED VENDORS
10.5.2 STARS
10.5.3 EMERGING LEADERS
10.5.4 PERVASIVE PLAYERS
10.5.5 PARTICIPANTS
FIGURE 31 LEGIONELLA TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
10.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2021)
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 32 LEGIONELLA TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021
10.7 COMPETITIVE BENCHMARKING
10.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS
FIGURE 33 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN LEGIONELLA TESTING MARKET
TABLE 125 LEGIONELLA TESTING MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 126 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
TABLE 127 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
TABLE 128 LEGIONELLA TESTING MARKET: DETAILED LIST OF KEY START-UPS/SMES
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES
TABLE 129 LEGIONELLA TESTING MARKET: KEY PRODUCT LAUNCHES & REGULATORY APPROVALS
10.8.2 DEALS
TABLE 130 LEGIONELLA TESTING MARKET: KEY DEALS
10.8.3 OTHER DEVELOPMENTS
TABLE 131 LEGIONELLA TESTING MARKET: OTHER DEVELOPMENTS
11 COMPANY PROFILES (Page No. – 148)
(Business Overview, Products Offered, Recent Developments, MnM View SWOT analysis) *
11.1 KEY PLAYERS
11.1.1 INDUSTRIAL/WATER
11.1.1.1 Thermo Fisher Scientific
TABLE 132 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 34 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021)
11.1.1.2 Merck KGAA
TABLE 133 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2021)
11.1.1.3 Bio-Rad Laboratories
TABLE 134 BIO-RAD LABORATORIES: BUSINESS OVERVIEW
FIGURE 36 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2021)
11.1.1.4 IDEXX Laboratories
TABLE 135 IDEXX LABORATORIES: BUSINESS OVERVIEW
FIGURE 37 IDEXX LABORATORIES: COMPANY SNAPSHOT (2021)
11.1.1.5 Biomérieux SA
TABLE 136 BIOMÉRIEUX SA: BUSINESS OVERVIEW
FIGURE 38 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2021)
11.1.1.6 Becton, Dickinson and Company
TABLE 137 BECTON, DICKINSON, AND COMPANY: BUSINESS OVERVIEW
FIGURE 39 BECTON, DICKINSON, AND COMPANY: COMPANY SNAPSHOT (2021)
11.1.1.7 Eurofins Scientific
TABLE 138 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 40 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021)
11.1.1.8 Takara Bio
TABLE 139 TAKARA BIO: BUSINESS OVERVIEW
FIGURE 41 TAKARA BIO: COMPANY SNAPSHOT (2021)
11.1.1.9 Eiken Chemical
TABLE 140 EIKEN CHEMICAL: BUSINESS OVERVIEW
FIGURE 42 EIKEN CHEMICAL: COMPANY SNAPSHOT (2021)
11.1.1.10 Qiagen
TABLE 141 QIAGEN: BUSINESS OVERVIEW
FIGURE 43 QIAGEN: COMPANY SNAPSHOT (2021)
11.1.1.11 Genomadix
TABLE 142 GENOMADIX, INC.: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 INDUSTRIAL/WATER
11.2.1.1 Pall Corporation (DANAHER)
11.2.1.2 Phigenics, Llc
11.2.1.3 Environmental safety technologies
11.2.1.4 Hydrosense
11.2.1.5 Accepta
11.2.1.6 Luminultra technologies
11.2.1.7 Bioalert solutions
11.2.1.8 Aquacert
11.2.1.9 Pacific water technology
11.2.1.10 DTK Water
11.2.1.11 Sens solutions
11.2.2 HEALTHCARE
11.2.2.1 Alere (ABBOTT)
TABLE 143 ABBOTT: BUSINESS OVERVIEW
FIGURE 44 ABBOTT: COMPANY SNAPSHOT (2021)
11.2.2.2 Roche Diagnostics
TABLE 144 ROCHE DIAGNOSTICS: BUSINESS OVERVIEW
FIGURE 45 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2021)
11.2.2.3 Hologic
TABLE 145 HOLOGIC: BUSINESS OVERVIEW
FIGURE 46 HOLOGIC: COMPANY SNAPSHOT (2021)
11.2.2.4 Quidel Corporation
TABLE 146 QUIDEL CORPORATION: BUSINESS OVERVIEW
FIGURE 47 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021)
11.2.2.5 Pro-Lab Diagnostics
*Details on Business Overview, Products Offered, Recent Developments, MnM View, SWOT analysis might not be captured in case of unlisted companies.
12 APPENDIX (Page No. – 201)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS